| Elizabeth Horvath, DO | |
|
450 W Highway 22, Barrington, IL 60010-1919 | |
| (847) 381-9600 | |
| Not Available |
| Full Name | Elizabeth Horvath |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 32 Years |
| Location | 450 W Highway 22, Barrington, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720092117 | NPI | - | NPPES |
| P00191260 | Other | IL | RAILROAD MEDICARE |
| 036090069 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 036090069 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Good Shepherd Hospital | Barrington, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri-county Emergency Physicians Ltd | 2567412240 | 21 |
| Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
With organizations tackling mounting workloads with fewer resources, many are being forced to find ways to become more efficient and cut costs. Enterprise content management (ECM) software, like OnBase, can help by eliminating paper, manual tasks and sometimes entire steps from processes (http://onbase.com/English/Products/OnBaseProductModules). But for some organizations - government agencies, healthcare providers, insurers, and even mountain resorts - OnBase is more than just a cost cutter and way to improve efficiency.
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
› Verified 9 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
With organizations tackling mounting workloads with fewer resources, many are being forced to find ways to become more efficient and cut costs. Enterprise content management (ECM) software, like OnBase, can help by eliminating paper, manual tasks and sometimes entire steps from processes (http://onbase.com/English/Products/OnBaseProductModules). But for some organizations - government agencies, healthcare providers, insurers, and even mountain resorts - OnBase is more than just a cost cutter and way to improve efficiency.
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
› Verified 9 days ago
| Entity Name | Tri-county Emergency Physicians Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700810470 PECOS PAC ID: 2567412240 Enrollment ID: O20050131000438 |
News Archive
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
With organizations tackling mounting workloads with fewer resources, many are being forced to find ways to become more efficient and cut costs. Enterprise content management (ECM) software, like OnBase, can help by eliminating paper, manual tasks and sometimes entire steps from processes (http://onbase.com/English/Products/OnBaseProductModules). But for some organizations - government agencies, healthcare providers, insurers, and even mountain resorts - OnBase is more than just a cost cutter and way to improve efficiency.
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
› Verified 9 days ago
| Entity Name | Crystal Lake Immediate Care Physicians Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538517198 PECOS PAC ID: 2961783139 Enrollment ID: O20161229001875 |
News Archive
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
With organizations tackling mounting workloads with fewer resources, many are being forced to find ways to become more efficient and cut costs. Enterprise content management (ECM) software, like OnBase, can help by eliminating paper, manual tasks and sometimes entire steps from processes (http://onbase.com/English/Products/OnBaseProductModules). But for some organizations - government agencies, healthcare providers, insurers, and even mountain resorts - OnBase is more than just a cost cutter and way to improve efficiency.
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Horvath, DO Po Box 98, Barrington, IL 60010-0098 Ph: (616) 975-1845 | Elizabeth Horvath, DO 450 W Highway 22, Barrington, IL 60010-1919 Ph: (847) 381-9600 |
News Archive
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
With organizations tackling mounting workloads with fewer resources, many are being forced to find ways to become more efficient and cut costs. Enterprise content management (ECM) software, like OnBase, can help by eliminating paper, manual tasks and sometimes entire steps from processes (http://onbase.com/English/Products/OnBaseProductModules). But for some organizations - government agencies, healthcare providers, insurers, and even mountain resorts - OnBase is more than just a cost cutter and way to improve efficiency.
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
› Verified 9 days ago
Michael G Braun, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Mark Giacomin, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Viren M Gohil, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Dr. Ryan Salzman, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Il 22, Barrington, IL 60010 Phone: 847-842-4444 | |
Danish Haque, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Dr. Tracey L Hashemi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 405 Lake Zurich Rd, Barrington, IL 60010 Phone: 847-381-5599 Fax: 847-381-8042 | |
Christopher P Mcswane, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 |